Legal Opinion
Brooks v. Sanofi S.A.
District Court, D. Nevada
Decided April 13, 2020No. 2:20-cv-00565Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 DISTRICT OF NEVADA 6 * * * 7 THOMAS BROOKS, Case No. 2:20-CV-565 JCM (EJY) 8 Plaintiff(s), ORDER 9 v. 10 SANOFI, S.A., et al., 11 Defendant(s). 12 13 Presently before the court is Thomas Brooks’s (“plaintiff”) motion to remand. (ECF No. 14 6). GlaxoSmithKline LLC (“defendant”) filed a response (ECF No. 10), to which plaintiff 15 replied (ECF No. 12).1 16 Also before the court is defendant’s motion to stay case. (ECF No. 11). 17 I. Background 18 The instant action arises from plaintiff’s use of Zantac, which he alleges caused his 19 kidney and bladder…
2Cases cited14 opinions
- Landis v. North American Co.Supreme Court of the United States · 1936
- Frank D. Gaus v. Miles, Inc., an Indiana CorporationCourt of Appeals for the Ninth Circuit · 1992
- Saint Paul Mercury Indemnity Co. v. Red Cab Co.Supreme Court of the United States · 1938
- Jose Ibarra v. Manheim Investments, Inc.Court of Appeals for the Ninth Circuit · 2015
- Richard M. Sanchez v. Monumental Life Insurance CompanyCourt of Appeals for the Ninth Circuit · 1996
9 more not listed; retrieve them via the Exa API.